Upjohn price increases
Executive Summary
Prices to wholesalers of the anxiolytic Xanax and hypnotic Halcion raised 7%, representing the second round of price hikes for the two benzodiazepine products this year; in February Upjohn raised prices for the two products by about 14%. In addition, Upjohn is also increasing prices for Micronase and the NSAID Ansaid by 6%. The price increases appear to be a response to flattening sales volume. In the second quarter, Upjohn reported a decline in sales of Xanax, Halcion and Micronase. Corporate sales increased only 2% in the quarter.